{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:59:25Z","timestamp":1792173565699,"version":"4.4.0"},"reference-count":19,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Kedrion BioPharma"},{"name":"Kedrion Biopharma"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2054262","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T21:07:26Z","timestamp":1650402446000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?"],"prefix":"10.1080","volume":"18","author":[{"given":"Jerry","family":"Siegel","sequence":"first","affiliation":[{"name":"College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kappeler","sequence":"additional","affiliation":[{"name":"College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"https:\/\/www.businessinsider.in\/science\/news\/pfizer-biontech-ask-fda-to-authorize-two-dose-covid-19-vaccine-for-children-under-5\/articleshow\/89286495.cms."},{"key":"e_1_3_2_3_1","unstructured":"https:\/\/www.worldometers.info\/coronavirus\/coronavirus-death-toll\/."},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2116298"},{"key":"e_1_3_2_5_1","unstructured":"https:\/\/en.wikipedia.org\/wiki\/Rabies."},{"issue":"3","key":"e_1_3_2_6_1","first-page":"1","article-title":"Human rabies prevention--United States, 2008: recommendations of the advisory committee on immunization practices","volume":"57","author":"Manning SE","year":"2008","unstructured":"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al. Human rabies prevention--United States, 2008: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2008;57(RR\u20133):1\u20134.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.08.054"},{"key":"e_1_3_2_8_1","unstructured":"https:\/\/www.fda.gov\/drugs\/development-resources\/pediatric-research-equity-act-prea."},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1854000"},{"key":"e_1_3_2_10_1","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6613553\/."},{"key":"e_1_3_2_11_1","unstructured":"https:\/\/www.everydayhealth.com\/rabies\/people-died-of-rabies-in-the-us-the-most-in-a-decade\/."},{"key":"e_1_3_2_12_1","unstructured":"https:\/\/www.cdc.gov\/nchs\/fastats\/body-measurements.htm."},{"key":"e_1_3_2_13_1","unstructured":"https:\/\/www.hyperrab.com\/documents\/2533658\/2533707\/Prescribing+Information+HyperRAB+300.pdf\/813095ad-a0b7-48fd-b3a8-c531d418e148?t=1617208717698."},{"key":"e_1_3_2_14_1","first-page":"47","article-title":"Rabies immune globulin: ensuring administration safety","author":"Siegel J","year":"2019","unstructured":"Siegel J. Rabies immune globulin: ensuring administration safety. Pharm Pract News Spec Ed. Sept.12,2019:47\u201352.","journal-title":"Pharm Pract News Spec Ed"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00015404"},{"key":"e_1_3_2_16_1","unstructured":"https:\/\/www.ahrq.gov\/patients-consumers\/patient-involvement\/off-label-drug-usage.html#:~:text=Off%2Dlabel%20prescribing%20is%20when are%20for%20off%2Dlabel%20use."},{"key":"e_1_3_2_17_1","unstructured":"https:\/\/www.cancer.org\/treatment\/treatments-and-side-effects\/treatment-types\/off-label-drug-use.html."},{"key":"e_1_3_2_18_1","unstructured":"US Pharm. 2013;38(1):40\u201342. https:\/\/www.uspharmacist.com\/article\/off-label-promotion-is-free-speech."},{"key":"e_1_3_2_19_1","unstructured":"kedrab.com\/KEDRAB-prescribing-information.pdf."},{"key":"e_1_3_2_20_1","unstructured":"Sanofi Pasteur SA Rabies Immune Globulin (Human) USP heat treated Imogam rabies HT (package insert) Marcy L\u2019Etoile 2018 Google Scholar https:\/\/www.fffenterprises.com\/assets\/downloads\/product-information\/sanofi-pasteur\/pi-IMOGAM-RABIES-HT.pdf."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2054262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T20:59:25Z","timestamp":1707166765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2054262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2054262"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2054262","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2054262"}}